Research!America has released a report "Sequestration: Health Research at the Breaking Point," which demonstrates the damaging consequences of potential automatic spending cuts, or sequestration, to the nation's medical research enterprise and public health.
The report also offers examples on how these cuts would delay scientific discoveries that could lead to new treatments and cures for deadly diseases. This report provides:
• The estimated budget cuts to the National Institutes of Health, CDC, AHRQ, FDA and the National Science Foundation;
• Statements and testimonials from the leaders of these federal health agencies, as well as the patient community, academia and industry.
• Compelling budget comparisons to help illustrate the magnitude of these cuts.
• Charts illustrating the impact on NIH and NSF grants to research institutions, academic medical centers and small businesses throughout the country.
• Charts depicting the inevitable fiscal consequences of delaying research aimed at combating disabling and deadly diseases.
Specifically, the report shows sequestration could lead to cuts of nearly $2.4 billion to the NIH, $444 million to CDC, $29 million to AHRQ, $191 million to FDA and $538 million to the National Science Foundation.
To view the report in full, click here.
The report also offers examples on how these cuts would delay scientific discoveries that could lead to new treatments and cures for deadly diseases. This report provides:
• The estimated budget cuts to the National Institutes of Health, CDC, AHRQ, FDA and the National Science Foundation;
• Statements and testimonials from the leaders of these federal health agencies, as well as the patient community, academia and industry.
• Compelling budget comparisons to help illustrate the magnitude of these cuts.
• Charts illustrating the impact on NIH and NSF grants to research institutions, academic medical centers and small businesses throughout the country.
• Charts depicting the inevitable fiscal consequences of delaying research aimed at combating disabling and deadly diseases.
Specifically, the report shows sequestration could lead to cuts of nearly $2.4 billion to the NIH, $444 million to CDC, $29 million to AHRQ, $191 million to FDA and $538 million to the National Science Foundation.
To view the report in full, click here.
Related Articles on Healthcare Quality:
UC Davis CMO Dr. Allan Siefkin: Creating a Culture of Safety, Quality
Expensive Hospital Readmission Linked to Healthcare-Associated Infections
NQF Endorses All-Cause Unplanned Readmissions Measures